0001213900-21-009660.txt : 20210216 0001213900-21-009660.hdr.sgml : 20210216 20210216163824 ACCESSION NUMBER: 0001213900-21-009660 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 EFFECTIVENESS DATE: 20210216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Emmaus Life Sciences, Inc. CENTRAL INDEX KEY: 0000822370 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870419387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-389589 FILM NUMBER: 21639610 BUSINESS ADDRESS: STREET 1: 21250 HAWTHORNE BOULEVARD, SUITE 800 CITY: TORRANCE STATE: CA ZIP: 90503 BUSINESS PHONE: 310-214-0065 MAIL ADDRESS: STREET 1: 21250 HAWTHORNE BOULEVARD, SUITE 800 CITY: TORRANCE STATE: CA ZIP: 90503 FORMER COMPANY: FORMER CONFORMED NAME: MYnd Analytics, Inc. DATE OF NAME CHANGE: 20151211 FORMER COMPANY: FORMER CONFORMED NAME: CNS RESPONSE, INC. DATE OF NAME CHANGE: 20070313 FORMER COMPANY: FORMER CONFORMED NAME: STRATIVATION, INC. DATE OF NAME CHANGE: 20051115 D 1 primary_doc.xml X0708 D LIVE 0000822370 Emmaus Life Sciences, Inc. 21250 HAWTHORNE BOULEVARD SUITE 800 TORRANCE CA CALIFORNIA 90503 310-214-0065 DELAWARE MYnd Analytics, lnc. CNS RESPONSE, INC MYnd Analytics, Inc. CNS RESPONSE, INC. STRATIVATION, INC. Corporation true Yutaka Niihara 21250 Hawthorne Boulevard Suite 800 Torrance CA CALIFORNIA 90503 Executive Officer Director Willis Lee 21250 Hawthorne Boulevard Suite 800 Torrance CA CALIFORNIA 90503 Executive Officer Director Yasushi Nagasaki 21250 Hawthorne Boulevard Suite 800 Torrance CA CALIFORNIA 90503 Executive Officer Robert Dickey 21250 Hawthorne Boulevard Suite 800 Torrance CA CALIFORNIA 90503 Director Masaharu Osato 21250 Hawthorne Boulevard Suite 800 Torrance CA CALIFORNIA 90503 Director Wei Peu Zen 21250 Hawthorne Boulevard Suite 800 Torrance CA CALIFORNIA 90503 Director Jane Pine Wood 21250 Hawthorne Boulevard Suite 800 Torrance CA CALIFORNIA 90503 Director Ian Pine Zwicker 21250 Hawthorne Boulevard Suite 800 Torrance CA CALIFORNIA 90503 Director Pharmaceuticals $25,000,001 - $100,000,000 06c false 2021-02-09 false true Three year convertible promissory notes convertible after the first anniversary of the issue date into shares of Emmaus common stock at an initial conversion price of $1.48 per share false 0 None None None None NONE NONE NONE XX Unknown 000000 CA CALIFORNIA true 17000000 1920000 15080000 false 10 0 0 0 true The proceeds of the offering will be used for working capital and general corporate purposes, which could include the payment of salaries to executive officers and director fees. false Emmaus Life Sciences, Inc. /s/ Dale Short Dale Short General Counsel 2021-02-16